Laura C Chambers1, Christine M Khosropour1, David A Katz2,3, Julia C Dombrowski1,2,3, Lisa E Manhart1,4, Matthew R Golden1,2,3. 1. Department of Epidemiology, University of Washington, Seattle. 2. Department of Medicine, University of Washington, University of Washington, Seattle. 3. Public Health-Seattle and King County HIV/STD Program, University of Washington, Seattle. 4. Department of Global Health, University of Washington, Seattle.
Abstract
Background: Chlamydia trachomatis is the most common reportable infection in the United States and can cause pelvic inflammatory disease (PID) and tubal factor infertility (TFI). Methods: We created life tables to estimate the "lifetime" risk of chlamydia diagnosis among women aged 15-34 years in King County, Washington, between 1992 and 2014. We estimated the lifetime risk of chlamydia-associated PID and TFI incorporating published estimates of the risk of sequelae. Results: There were 51464 first chlamydia diagnoses in 1992-2014. For women born between 1980 and 1984, the lifetime risk of chlamydia diagnosis was 19.8% overall and 14.0% for non-Hispanic white, 64.9% for non-Hispanic black, and 32.6% for Hispanic women. The cumulative risk of chlamydia by age 24 increased overall from 13.9% to 17.3% among women born between 1975 and 1994 but declined among non-Hispanic black women, among whom risk by age 24 declined from 57.3% among women born between 1980 and 1984 to 38.6% among women born between 1990 and 1994. The lifetime risk of chlamydia-associated PID among women born between 1980 and 1984 ranged from 0.33% to 1.14%. Among non-Hispanic white, non-Hispanic black, and Hispanic women, the lifetime risk of chlamydia-associated TFI was 0.04%, 0.20%, and 0.10%, respectively. Conclusions: Over 60% of non-Hispanic black women had at least 1 chlamydia diagnosis by age 34 in the birth cohorts most affected, a risk almost 5 times that in non-Hispanic whites. An estimated 1 in 500 non-Hispanic black women develops chlamydia-associated TFI. More effective control measures are needed.
Background: Chlamydia trachomatis is the most common reportable infection in the United States and can cause pelvic inflammatory disease (PID) and tubal factor infertility (TFI). Methods: We created life tables to estimate the "lifetime" risk of chlamydia diagnosis among women aged 15-34 years in King County, Washington, between 1992 and 2014. We estimated the lifetime risk of chlamydia-associated PID and TFI incorporating published estimates of the risk of sequelae. Results: There were 51464 first chlamydia diagnoses in 1992-2014. For women born between 1980 and 1984, the lifetime risk of chlamydia diagnosis was 19.8% overall and 14.0% for non-Hispanic white, 64.9% for non-Hispanic black, and 32.6% for Hispanic women. The cumulative risk of chlamydia by age 24 increased overall from 13.9% to 17.3% among women born between 1975 and 1994 but declined among non-Hispanic black women, among whom risk by age 24 declined from 57.3% among women born between 1980 and 1984 to 38.6% among women born between 1990 and 1994. The lifetime risk of chlamydia-associated PID among women born between 1980 and 1984 ranged from 0.33% to 1.14%. Among non-Hispanic white, non-Hispanic black, and Hispanic women, the lifetime risk of chlamydia-associated TFI was 0.04%, 0.20%, and 0.10%, respectively. Conclusions: Over 60% of non-Hispanic black women had at least 1 chlamydia diagnosis by age 34 in the birth cohorts most affected, a risk almost 5 times that in non-Hispanic whites. An estimated 1 in 500 non-Hispanic black women develops chlamydia-associated TFI. More effective control measures are needed.
Authors: Thomas A Peterman; Lin H Tian; Carol A Metcalf; Catherine L Satterwhite; C Kevin Malotte; Nettie DeAugustine; Sindy M Paul; Helene Cross; Cornelis A Rietmeijer; John M Douglas Journal: Ann Intern Med Date: 2006-10-17 Impact factor: 25.391
Authors: William C Miller; Carol A Ford; Martina Morris; Mark S Handcock; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry Journal: JAMA Date: 2004-05-12 Impact factor: 56.272
Authors: Thomas A Peterman; Daniel R Newman; Elizabeth Torrone; Karla Schmitt; Stacy Shiver Journal: J Adolesc Health Date: 2014-04-03 Impact factor: 5.012
Authors: Sarah C Woodhall; Gillian S Wills; Patrick J Horner; Rachel Craig; Jennifer S Mindell; Gary Murphy; Myra O McClure; Kate Soldan; Anthony Nardone; Anne M Johnson Journal: PLoS One Date: 2017-01-27 Impact factor: 3.240
Authors: Sarah Wood; Jungwon Min; Vicky Tam; Julia Pickel; Danielle Petsis; Kenisha Campbell Journal: Am J Public Health Date: 2022-01 Impact factor: 9.308
Authors: Margaret M Tomcho; Yingbo Lou; Sonja C O'Leary; Deborah J Rinehart; Tara Thomas-Gale; Claudia M Douglas; Florence J Wu; Lara Penny; Steven G Federico; Holly M Frost Journal: Pediatrics Date: 2021-10-21 Impact factor: 7.124
Authors: Rodman Turpin; Susan Tuddenham; Xin He; Mark A Klebanoff; Khalil G Ghanem; Rebecca M Brotman Journal: J Infect Dis Date: 2021-08-16 Impact factor: 7.759
Authors: Minttu M Rönn; Nicolas A Menzies; Thomas L Gift; Harrell W Chesson; Tom A Trikalinos; Meghan Bellerose; Yelena Malyuta; Andrés Berruti; Charlotte A Gaydos; Katherine K Hsu; Joshua A Salomon Journal: Clin Infect Dis Date: 2020-04-15 Impact factor: 9.079